Table 2 Posterior capsular opacity and postoperative complications after phaco-vitrectomy for Idiopathic epiretinal membrane

PCO, n (%)

20 (13.2%)

0

0.001*

 Onset (months), mean ± SD

10.59 ± 2.88

0

 Nd:YAG posterior capsulotomy, n (%)

9 (45.0%)

0

Anterior chamber inflammation, n (%)

4 (2.6%)

1 (1.3%)

0.522*

Corneal edema, n (%)

2 (1.3%)

3 (3.9%)

0.201*

IOP increase, n (%)

1 (0.7%)

0

0.479*

IOL decenter, tilt or dislocation, n (%)

0

0

Anterior capsular phimosis, n (%)

1 (0.7%)

2 (2.6%)

0.218*

CME, n (%)

10 (6.6%)

12 (15.8%)

0.026*

 Onset (months), mean ± SD

1 ± 0

1.17 ± 0.57

0.374^†

 Duration (months), mean ± SD

1.50 ± 0.71

3.36 ± 2.20

0.019^†

 Treatment, n (%)

0.130*

  Observation

0

3 (25.0%)

  Topical eye drops

10 (100%)

8 (66.7%)

  Intravitreal TA injection

0

1 (8.3%)

Postoperative retinal breaks, n (%)

2 (1.3%)

0

0.315*

ERM recurrence, n (%)

26 (17.1%)

12 (15.8%)

0.802*

 Onset (months), mean ± SD

5.81 ± 4.30

6.67 ± 4.33

0.571^†